Oxidized low-density lipoprotein (oxLDL) is known to induce apoptosis in endothelial cells, and this is believed to contribute to the progression of atherosclerosis. In the present study we made the novel observation that oxLDL-induced death of HMEC-1 cells is accompanied by activation of calpain. The µ-calpain inhibitor PD 151746 decreased oxLDL-induced cytotoxicity, whereas the general caspase inhibitor BAF (t-butoxycarbonylAsp-methoxyfluoromethylketone) had no effect. Also, oxLDL provoked calpain-dependent proteolysis of cytoskeletal α-fodrin in the HMEC-1 cells. Our observation of an autoproteolytic cleavage of the 80 kDa subunit of µ-calpain provided further evidence for an oxLDL-induced stimulation of calpain activity. The Bcl-2 protein Bid was also cleaved during oxLDL-elicited cell death, and this was prevented by calpain inhibitors, but not by inhibitors of cathepsin B and caspases. Treating the HMEC-1 cells with oxLDL did not result in detectable activation of procaspase 3 or cleavage of PARP [poly(ADP-ribose) polymerase], but it did cause polyubiquitination of caspase 3, indicating inactivation and possible degradation of this protease. Despite the lack of caspase 3 activation, oxLDL treatment led to the formation of nucleosomal DNA fragments characteristic of apoptosis. These novel results show that oxLDL initiates a calpain-mediated death-signalling pathway in endothelial cells.
INTRODUCTION
Oxidized low-density lipoprotein (oxLDL) plays a central role in atherogenesis [1, 2] , and it is assumed that oxLDL-induced apoptosis and/or necrosis of vascular cells contributes to the progression of atherosclerosis (reviewed in [3] ). OxLDL is well recognized as a pro-apoptotic agent in the endothelium, and has previously been reported to induce death of human umbilicalvein and coronary-artery cells, as well as bovine aortic endothelial cells [4] [5] [6] . Thus far, the signalling proteins implicated in oxLDLelicited cell death include caspases, FLIP {FLICE [FADD (Fasassociated death domain)-like interleukin-1β-converting enzyme] inhibitory protein}, protein kinase C and protein tyrosine kinases [5, 7, 8] .
Calpains are Ca 2+ -dependent cysteine proteases that are known to be involved in the proteolysis of a number of proteins during mitosis, apoptosis and necrosis. The calpains appear to perform a key function in certain models of apoptosis, including the death program induced by tumour necrosis factor in U937 cells [9] and by glucocorticoids in thymocytes [10] . Furthermore, activation of calpain has been shown to induce apoptosis-like events in platelets [11] , and also seems to be important for excitotoxic neuronal death [12, 13] . The calpains constitute a large family of distinct isoenzymes that differ in structure and distribution [14] , and two members of this family, namely µ-calpain and m-calpain, are ubiquitous. The specific endogenous protein inhibitor calpastatin modulates calpain activity in vivo [15] . Moreover, we have shown [16] , as have other researchers [17] , that calpastatin is cleaved Abbreviations used: Ab, antibody; BAF, t-butoxycarbonyl-Asp-methoxyfluoromethylketone; [Ca 2+ ] i , concentration of intracellular free Ca 2+ ; DEVD-amc, Asp-Glu-Val-Asp-aminomethylcoumarin; FBS, foetal-bovine serum; HUVEC, human umbilical-vein endothelial cells; LDH, lactate dehydrogenase; mAb, monoclonal antibody; (ox)LDL, (oxidized) low-density lipoprotein; PARP, poly(ADP-ribose) polymerase; pAb, polyclonal antibody; ROS, reactive oxygen species; TBARS, thiobarbituric acid-reactive substances; TBS, Tris-buffered saline; TEP, tetraethoxypropane; (z)VAD-fmk, (butyloxycarbonyl-)Val-Ala-Aspmethoxyfluoromethylketone. 1 To whom correspondence should be addressed (e-mail isabella.ares@exppat.mas.lu.se).
during apoptosis, which may lead to increased calpain activity, and such cleavage can be achieved by calpains or caspases, depending on the cell type and the stimulus inducing apoptosis. The cytoskeletal protein α-fodrin is another death substrate that may be cleaved by calpains or caspases [9, 18, 19] . Additional calpain substrates known to be involved in apoptosis are Bax [20, 21] , Bid [22] , p53 [23] and procaspases 3, 7, 8 and 9 [11, 24, 25] . Caspases (aspartic acid-specific cysteine proteases) have been identified as the main players in most models of apoptosis, because they are responsible for triggering and carrying out apoptotic demise induced by both death-receptor ligation and drugs (reviewed in [26] ). A number of researchers have reported that caspases are involved in oxLDL-induced cell death [6, 27, 28] , and the experiments in those studies were conducted using high (> 20 µM) concentrations of the general caspase inhibitor VADfmk (Val-Ala-Asp-methoxyfluoromethylketone). In that context, other investigators have observed unexpected inhibition of calpain activity by VAD-fmk [11, 13, 29] , and it has been demonstrated that oxLDL-induced apoptosis in endothelial cells requires Ca 2+ [4] . Furthermore, oxLDL is well known to induce oxidative stress, and oxidative stress up-regulates calpain expression [30] . In light of these findings we examined the possibility that calpains participate in oxLDL-elicited death of endothelial cells.
Our results revealed a novel type of oxLDL-initiated death signalling in endothelial cells, which involves activation of calpain, cleavage of α-fodrin and Bid, and inactivation of caspase 3 by polyubiquitination. 
EXPERIMENTAL

Cell culture
The human dermal microvascular cell line HMEC-1 [31] was obtained from the Centers for Disease Control and Prevention (CDC; Atlanta, GA, U.S.A.). The cells were cultured in MCDB 131 medium supplemented with 2 mM L-glutamine, 50 i.u./ml penicillin/streptomycin (all from Gibco BRL Life Technologies, Gaithersburg, MD, U.S.A.), 10 % (v/v) heat-inactivated foetalbovine serum (FBS), 10 ng/ml epidermal growth factor and 1 µg/ml cortisol. The cells were maintained at 37
• C in a humidified incubator under 5 % CO 2 .
Isolation and oxidation of LDL
Plasma was obtained from healthy volunteers with their informed consent, and lipoproteins were isolated by sequential flotation ultracentrifugation [32] . Isolated LDL [density (ρ) = 1.019-1.063 g/ml] was desalted on an Econo-Pac 10 DG chromatography column (Bio-Rad, Hercules, CA, U.S.A.) and sterile-filtered (0.22 µm pore size; Millipore, Bedford, MA, U.S.A.); the LDL was stored under N 2 at + 4
• C, but was used within 4 weeks of preparation. The protein content of newly isolated LDL was determined by the Lowry method.
To oxidize LDL, the lipoprotein (0.5 mg/ml in sterile PBS) was incubated with 5 µM CuSO 4 at 37
• C for 20 h. Oxidized LDL was concentrated by centrifuging in Amicon Centriplus YM-100 tubes (Millipore Corp., Bedford, MA, U.S.A.) for 2 h at 3000 g and 8
• C, and subsequently sterile-filtered. The oxidation was confirmed by measuring thiobarbituric acid-reactive substances (TBARS) using tetraethoxypropane (TEP) as a standard [33] . The TBARS assay is based on the reaction of malonaldehyde, a lipid hydroperoxide degradation product, with thiobarbituric acid. The TBARS content of oxLDL used in our study was 25-45 nmol of TEP equivalents/mg of protein. We used the oxLDL within 24 h of preparation, and endothelial cells were incubated with oxLDL dissolved in culture medium containing 1 % FBS.
To exclude unspecific effects of possible residual Cu 2+ in the oxLDL preparation, we performed control experiments with analyses of cell toxicity and α-fodrin fragmentation, but we did not find any effects of Cu 2+ in the relevant concentration range (results not shown).
Analysis of cytotoxicity
The level of cytotoxicity induced by oxLDL was analysed using a Roche Cytotoxicity Detection Kit, which measures release of lactate dehydrogenase (LDH) from cells with compromised membrane integrity. The analysis was performed according to the instructions of the manufacturer, and native LDL was used as control treatment. The 100 % value of cytotoxicity (LDH leakage) was obtained from samples permeabilized with 1 % Triton X-100, which resulted in the release of all LDH activity into the supernatant.
Caspase assay
Activity of caspase 3 in HMEC-1 cells was analysed with a fluorescence spectrophotometric assay, using the fluorogenic peptide DEVD-amc as a substrate. After various treatments, cells were harvested by scraping them into 300 µl of caspase lysis buffer [10 mM Tris/HCl/10 mM NaH 2 PO 4 /Na 2 HPO 4 (pH 7.5)/ 130 mM NaCl/0.1 % Triton-X-100/10 mM sodium pyrophosphate] on ice. Floating cells were collected, pelleted and pooled with the lysate. The assay was performed in white Fluoronunc TM Polysorp 96-well plates (Nunc A/S, Roskilde, Denmark). Lysates (50 µl aliquots) were added to the reaction wells, together with 200 µl of Hepes buffer [20 mM Hepes (pH 7.5)/10 % (v/v) glycerol/2 mM dithiothreitol] and 4 µl of DEVD-amc (dissolved in DMSO). The reaction mixture was incubated at 37
• C for 1 h, after which amc fluorescence was analysed using a Fluostar plate reader (BMG Lab Technologies, Offenburg, Germany), employing excitation and emission wavelengths of 390 and 460 nm respectively. The protein content of lysates was assayed by using Pierce's Coomassie ® Plus Protein Assay Reagent.
Immunoprecipitation
For immunoprecipitation of caspase 3, HMEC-1 cells were cultured in 100 mm-diameter culture dishes, treated in appropriate ways, and then scraped into 800 µl of immunoprecipitation buffer [150 mM NaCl/10 mM Tris/HCl (pH 7.4)/1 mM EDTA/ 1 mM EGTA/2 mM orthovanadate/2 mM Pefabloc ® /1 % (v/v) Nonidet P40]. The resulting lysate was pre-cleared with Protein A-Sepharose, and caspase 3 was immunoprecipitated with an agarose-conjugated anti-(caspase 3) Ab (20 µg/ml). The immunoprecipitate was washed four times with the abovementioned buffer, resuspended in 2 × sample buffer [125 mM Tris/HCl (pH 6.8)/4 % (w/v) SDS/20 % (v/v) glycerol/0.05 % Bromophenol Blue/100 mM dithiothreitol], heated to 90
• C for 5 min, and then loaded on to SDS/polyacrylamide gels and subjected to Western blotting.
Preparation of cell lysates and Western-blot analysis
After various treatments in 60 mm-diameter culture dishes, floating cells were collected and pelleted, and adherent cells were harvested by scraping into 250 µl of Western lysis buffer [150 mM NaCl/20 mM Tris/HCl (pH 7.4)/5 mM EDTA/2 mM orthovanadate/4 µg/ml leupeptin/60 µg/ml PMSF/1 % Nonidet P40]. The pelleted cells were pooled with the lysate, and 60 µl of 5 × sample buffer was added to each sample, and the samples were heated to 90
• C in a heating block for 5 min. Proteins were separated under reducing conditions at 120 V in SDS/polyacrylamide gels and then Western-blotted on to PVDF filters at 100 V. Blots were blocked with Tris-buffered saline (TBS; 50 mM Tris base/150 mM NaCl/0.05 % Tween-20) containing 5 % (w/v) dry milk powder, and then incubated for 1-2 h with anti-α-fodrin mAb (1:1000), anti-(proteolysed fodrin) pAb ( [34] ; diluted 1:200), anti-(caspase 3) mAb (1:500), anti-Bid pAb (1:1000), anti-ubiquitin mAb (1:400), anti-α-tubulin mAb (1:500), anti-µ-calpain mAb (1:1000) or anti-PARP mAb (1:5000). The blots were subsequently washed in TBS for 30 min and then incubated with a peroxidase-conjugated secondary Ab. Bound Ab was assayed by enhanced chemiluminescence detection (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.).
Assessment of apoptosis
To evaluate the type of death induced by oxLDL, HMEC-1 cells were cultured in 96-well plates and incubated with or without oxLDL for 12 h. Thereafter, the level of internucleosomal (apoptotic) DNA fragmentation was determined by Ab-mediated capture and detection of cytoplasmic mononucleosome-and oligonucleosome-associated histone-DNA complexes, using the Cell Death Detection ELISA PLUS kit. The ELISA assay was performed according to the instructions of the manufacturer. Briefly, endothelial cells were washed and incubated with 200 µl of lysis buffer for 30 min. After pelleting nuclei (200 g, 10 min), 20 µl of the supernatant (cytoplasmic fraction) was used in the ELISA. Finally, A 405 , upon incubating with a peroxidase substrate for 15 min, was determined with a Fluostar microplate reader. Values from wells containing lysis buffer and substrate only were subtracted as background. 
RESULTS
Cytotoxicity of oxLDL in HMEC-1 cells
The cytotoxicity and death-inducing capacity of oxLDL have been observed in several types of cells. We performed LDH assays to determine the level of toxicity in HMEC-1 cells incubated with various concentrations of oxLDL. The results show that 100 µg/ml oxLDL led to approx. 58 % cytotoxicity within 24 h ( Figure 1A) , and we chose to use this concentration in further experiments conducted to study the involvement of proteases in oxLDL-induced cell death.
Proteases involved in oxLDL cytotoxicity
To explore the possible involvement of caspases and calpain in oxLDL-induced cell death, we exposed cells to the general caspase inhibitor BAF and to the µ-calpain inhibitor PD 151746. BAF did not provide any protection against oxLDL toxicity ( Figure 1B) , and 10 µM VAD-fmk was equally ineffective (results not shown). We did not use higher concentrations of the latter inhibitor, because it has been shown that such treatment causes non-specific inhibition of calpains [11, 13, 29] . On the other hand, the µ-calpain inhibitor (20 µM PD 151746) did provide a considerable degree of protection against oxLDL-induced death (a decrease of approx. 40 %). Consequently, it seems that the activity of µ-calpain, but not caspases, was necessary for the execution of oxLDL-induced death of HMEC-1 cells. The statistical significance of the effects of the inhibitors was calculated using Student's t test; *P < 0.05.
Apoptotic DNA fragmentation induced by OxLDL in HMEC-1 cells
The results of LDH assays merely reflect the level of cytotoxicity and do not distinguish between the two major types of cell death: apoptosis and necrosis. Therefore we used an ELISA assay to study the possible formation of nucleosomal DNA fragments in HMEC-1 cells incubated with oxLDL for 12 h. We found that oxLDL induced a dose-dependent increase in the formation of histone-associated cytoplasmic DNA fragments (Figure 2A) , showing that oxLDL indeed induced apoptosis in HMEC-1 cells. Exposure of the cells to PD 151746 in combination with oxLDL resulted in a significant decrease of DNA fragmentation, whereas BAF did not provide any protection ( Figure 2B ). Thus our data suggest that calpain activity, but not caspase activity, is important for oxLDL-induced apoptotic DNA fragmentation.
Cleavage of α-fodrin induced by oxLDL
Cleavage of the cytoskeletal protein α-fodrin has been observed in many types of cell death, but has not, to our knowledge, been studied in cells exposed to oxLDL. We performed Western-blot analysis, and found that treating HMEC-1 cells with oxLDL for 20 h led to a dose-dependent increase in α-fodrin proteolysis, accompanied by formation of the typical fragments of 150/145 and 120 kDa ( Figure 3A) . Exposing the cells to oxLDL caused a particularly pronounced increase in the 150/145 kDa fragments, whereas the dominating fragment generated by staurosporineinduced cleavage of α-fodrin was 120 kDa in size ( Figure 3A) . No cleavage of α-fodrin occurred in parallel incubations with native LDL (results not shown). In previous studies we have found [9] , as have others [18, 19] , that both calpains and caspases are capable of cleaving α-fodrin, and, depending on the kind of cell being studied, either one or both of these types of enzymes may be involved in such cleavage during apoptosis. Furthermore, it has been reported that the 150/145 kDa fragments can be formed by the actions of both calpains and caspases, whereas the 120 kDa fragment is thought to be produced primarily by caspase action [19] . This was confirmed in our experiments in which we co-exposed HMEC-1 cells to oxLDL and protease inhibitors ( Figure 3A) . We therefore assumed that the predominant generation of 150/145 kDa fragments of α-fodrin induced in HMEC-1 cells by treatment with oxLDL is a sign of calpain activation.
Calpain-mediated cleavage of α-fodrin during oxLDL-induced cell death
Use of Western-blot analysis and a specific Ab to detect a calpain-proteolysed α-fodrin fragment has proven to be one of the most reliable methods to demonstrate calpain activation in cell lysates [18, 34] . We employed a polyclonal Ab specific for the calpain-proteolysed 150 kDa α-fodrin fragment [34] to determine whether calpain activation occurs in HMEC-1 cells treated with oxLDL. We detected increased amounts of the calpain-generated 150 kDa α-fodrin breakdown product in HMEC-1 cells exposed to 50 µg/ml oxLDL, and there was a dose-dependent increase in the intensity of this band ( Figure 3B ). The 150 kDa α-fodrin band became visible after 12 h of oxLDL treatment and increased in strength up to 24 h (results not shown). Furthermore, co-treatment with calpain inhibitors calpeptin or PD 151746 prevented oxLDLinduced formation of the 150 kDa fragment ( Figure 3C ), whereas BAF was without effect. These results confirm the calpaincatalysed cleavage of α-fodrin, and show that oxLDL induces activation of calpain in endothelial cells.
Autoproteolytic cleavage of calpain upon exposure of HMEC-1 cells to oxLDL
The autoproteolytic cleavage of the 80 kDa subunit of µ-and mcalpain is known to be associated with activation of these enzymes [14] . To further verify the activation of calpain in response to oxLDL exposure, we used a mAb against the 80 kDa subunit of µ-calpain on Western blots, and we observed a dose-dependent formation of the 78 kDa autoproteolysis product of µ-calpain upon treatment of HMEC-1 cells with oxLDL ( Figure 3D ). The detection of cleaved µ-calpain provided further evidence for an oxLDL-induced stimulation of calpain activity in HMEC-1 cells.
Increased level of [Ca 2+ ] i in oxLDL-treated HMEC-1 cells
OxLDL has been shown to induce elevations of [Ca 2+ ] i , and the oxLDL-induced toxicity to cultured cells has been suggested to be mediated through a delayed (10-12 h) Ca 2+ peak [35] . To confirm that oxLDL induces an increase in [Ca 2+ ] i in HMEC-1 cells, we performed measurements of [Ca 2+ ] i in oxLDLtreated cells, employing the fluorescent indicator Fluo-3. As shown in Figure 4 , we found a significant elevation of the basal [Ca 2+ ] i in HMEC-1 cells treated for 10 and 12 h with 100 µg/ml oxLDL. The increase in [Ca 2+ ] i preceded the observed activation of µ-calpain and gives further support to the novel type of oxLDLinitiated death signalling in endothelial cells, which involves activation of this Ca 2+ -dependent protease.
Proteolysis of Bid in oxLDL-treated HMEC-1 cells
To further characterize the death signal induced by oxLDL in HMEC-1 endothelial cells, we studied the pro-apoptotic BH3-domain-only protein Bid, which is reportedly a substrate for calpain [22] . Truncated Bid is thought to mediate cell death via oligomerization of Bax and/or Bak, with subsequent release of cytochrome c from the mitochondria [22, 36] . We observed a dose-dependent decrease in the ≈ 22 kDa band recognized by the anti-Bid Ab in HMEC-1 cells incubated with oxLDL for 20 h ( Figure 5A ). . The statistical significance of the increase in cytosolic free Ca 2+ was calculated using Student's t test; *P < 0.05, **P < 0.01. and oxLDL to track the protease responsible for Bid cleavage in the present system. The results show that only PD 151746 protected Bid from cleavage in HMEC-1 cells, whereas neither the cathepsin B inhibitor CA-074, nor the caspase inhibitor BAF, had any effect ( Figures 5B and 5C ). We used CA-074 {[l,3-trans-(propylcarbamoyl)oxirane-2-carbonyl]-l-isoleucyl-l-proline} at a concentration of 10 µM, because we found that higher levels were toxic per se to the cells (results not shown). This suggests that calpain-catalysed proteolysis of Bid occurs in endothelial cells exposed to oxLDL.
Caspase 3 is not activated during oxLDL-induced death of HMEC-1 cells
Because other researchers have suggested that oxLDL-induced cell death is mediated by caspases [6, 27, 28] , we examined the effects of oxLDL on activation of caspase 3 in HMEC-1 endothelial cells. PARP is a well-known substrate of caspase 3 that is cleaved early in most types of apoptosis. We found that cleavage of PARP in HMEC-1 cells was not induced by exposure to oxLDL for 20 h, but was very pronounced upon treatment with staurosporine ( Figure 6A ). Furthermore, Western-blot analysis of procaspase 3 revealed no significant proteolytic activation in oxLDL-treated HMEC-1 cells, whereas staurosporine led to production of the 17 kDa catalytic subunit of caspase 3 ( Figure 6B) . A weak band of 17 kDa appeared in the lysates of cells treated with the highest concentration of oxLDL. More importantly, 100 µg/ml oxLDL did not induce any formation of active p17, whereas this concentration did induce cell death (Figures 1 and 2) . To further verify the absence of caspase 3 activation in our cell system, we performed a DEVD-amc-cleavage assay on lysates of HMEC-1 cells. We found no stimulation of the DEVD-amc-cleavage activity in oxLDL-treated HMEC-1 cells, as compared with untreated or LDL-treated cells, whereas exposure to staurosporine caused marked stimulation of caspase 3 activity (Table 1) . Indeed, we observed that LDL and oxLDL actually induced a decrease in DEVD-amc-cleavage activity, as compared with control cells. The data presented in Table 1 represent cells subjected to the different treatments for 14 h. We also incubated cells with oxLDL for 6 and 24 h to study the effects on DEVD-amc cleavage, but in no case did we observe any stimulation (results not shown). 
OxLDL-induced polyubiquitination of caspase 3
Interestingly, treatment of HMEC-1 cells with oxLDL caused a dose-dependent increase in high-molecular-mass (> 100 kDa) bands recognized by the anti-(caspase 3) mAb ( Figure 6B) , suggesting a possible oxLDL-induced ubiquitination of caspase 3. Ubiquitination (covalent conjugation of 8.5 kDa ubiquitin molecules, in the form of multi-ubiquitin chains) of caspases has recently been reported to inactivate these enzymes [39, 40] . Therefore, we immunoprecipitated caspase 3 from HMEC-1 cells and probed the Western blots of these immunoprecipitates with an Ab against ubiquitin. We found that exposing the cells to oxLDL clearly induced polyubiquitination of caspase 3, whereas treatment with native LDL did not ( Figure 6C ). 
DISCUSSION
As mentioned in the Introduction, it is well known that oxLDL is a proapoptotic agent in endothelium, and it is assumed that vascular cell death induced by oxLDL contributes to the progression of atherosclerosis (reviewed in [3] ). Calpain has previously been suggested to mediate endothelial apoptosis induced by growthfactor deprivation [41, 42] . We found that calpain plays an In further evidence of calpain involvement in oxLDL-induced cell death, we observed that this lipoprotein caused a dosedependent decrease in cellular levels of Bid. Caspase 8, cathepsin B, and calpain have all been shown to cleave Bid in various cell models [22, 37, 38] , but the results of our experiments suggest that a calpain was responsible for the proteolysis of Bid in HMEC-1 cells. More precisely, we found that protection against cleavage of Bid was offered by PD 151746, but not by the cathepsin B inhibitor CA-074 or the caspase inhibitor BAF.
The relevance of Bid cleavage in the present system is not yet clear, since it is presumed that the cell death caused by truncated Bid is mediated by release of cytochrome c and subsequent caspase activation. Inasmuch as caspase 3 seems to be inactivated in the system we studied, it is possible that other mechanisms are involved in cell death promoted by truncated Bid. OxLDL treatment also caused the appearance of a weak band corresponding to the 120 kDa α-fodrin fragment, inhibitable by BAF treatment, suggesting that a caspase was activated upon oxLDL treatment. Our observations that Bid was activated by calpain, and that α-fodrin may be cleaved partly by a caspase, are in good agreement with previous reports showing that calpain activation can lead to caspase activation [11, 13, 29, 43] . The identity of this caspase is unclear, but more importantly, BAF did not confer any protection against oxLDL-induced cytotoxicity in HMEC-1 cells.
Caspase 3 is believed to be the most important enzyme in the apoptosis program; yet, our experiments show unequivocally that oxLDL did not stimulate caspase 3 activity in HMEC-1 endothelial cells. We detected neither cleavage of PARP, nor any proteolytic activation of procaspase 3, in oxLDL-treated HMEC-1 cells. Nevertheless, the caspase pathway seemed to be functioning normally in the cells, as evidenced by massive, staurosporineinduced activation of caspase 3. Furthermore, compared with untreated or LDL-treated cells, those exposed to oxLDL did not exhibit stimulated DEVD-amc-cleavage activity. In fact, the level of DEVD-amc cleavage was lower in cells treated with LDL and oxLDL than in control cells. It is not surprising that the basal level of caspase 3 activity was reduced by LDL, because this lipoprotein has been found to have mitogenic effects [44, 45] . A plausible explanation for the oxLDL-elicited inhibition of caspase 3 activity is the ubiquitination of caspase 3 observed in our study. The discovery that caspase inhibitors in no way protected against oxLDL-mediated toxicity further supports the conclusion that cell death caused by oxLDL does not depend on the activation of caspases in HMEC-1 endothelial cells. Recent reports have indicated that caspases may be inactivated by ubiquitination [39, 40] , and we found that polyubiquitination of caspase 3 was induced by oxLDL in the HMEC-1 cells. To our knowledge, we are the first to demonstrate oxLDL-induced ubiquitination of caspase 3, although Vieira et al. [46] have proposed that the rate of ubiquitination of cellular proteins in general may be increased by oxLDL. Taken together, our results suggest that caspases are not important for oxLDL-induced death of endothelial cells. This is refuted by investigations suggesting that inhibition of caspases protects against oxLDL-mediated cell death [6, 27, 28] . Unfortunately, the identity of the death-mediating protease(s) in the cited studies remains unknown, because the high concentrations (> 20 µM) of VAD-fmk used in those experiments have been shown to cause unspecific inhibition of calpains [11, 13, 29] . Nevertheless, studying HUVEC (human umbilical-vein endothelial cells), Dimmeler and co-workers [7] found that caspase 3 was activated by 10 µg/ml oxLDL, and this type of cell death could also be prevented by moderate concentrations of caspase inhibitors [7] . In our study we found no response to such a low concentration of oxLDL, and our observations of caspase 3 ubiquitination and calpain activation indicate novel and alternative signalling pathways initiated by oxLDL. However, the protein concentration of oxLDL is only a relative measure, and, depending on the extent of LDL oxidation, 10 µg/ml can induce various levels of oxidative stress in the cells. In the abovementioned study [7] , the oxidation level of LDL was not clearly expressed, and thus it is not possible to directly compare these two studies. Importantly, despite the lack of caspase 3 activation in the present study, oxLDL treatment led to the calpain-dependent formation of nucleosomal DNA fragments characteristic of apoptosis. This observation is in good agreement with a recent report showing caspase-independent apoptotic DNA fragmentation, inhibitable by calpain inhibitors, in vitamin D 3 -induced cell death of human breast-cancer cells [47] .
OxLDL contains an undefined mixture of oxidized lipids (aldehydes, oxysterols and lipid peroxides), and the toxicity of oxLDL has mainly been associated with the lipid fraction [35] . Exchange of oxidized lipids with the plasma membrane and receptor-mediated uptake of oxLDL particles are the main routes thought to be involved in the initiation of cytotoxicity. HMEC-1 cells express the scavenger receptors LOX-1 and CD36, which have both been implicated in the apoptotic effect of oxLDL. HUVEC cells, however, do not express CD36, and this could perhaps explain the differences in response to oxLDL exposure. Oxidized lipids from oxLDL induce modifications of cell protein structure, elicit generation of ROS (reactive oxygen species) and cellular lipid peroxidation, and thus alter the regulation of various signalling pathways. Importantly, oxidative stress has been shown to up-regulate calpain expression [30] .
OxLDL-generated intracellular ROS may inhibit plasmamembrane Ca 2+ /ATPases pumps, thereby contributing to the rise of cytosolic Ca 2+ , which activates Ca 2+ -dependent endonucleases and calpains.
Our results, together with reports that calpain is involved in the death program of U937 cells, thymocytes, platelets, neurons and breast-cancer cells [9] [10] [11] [12] [13] 47] , suggest that, in certain types of cell death, calpain activation is used as an alternative to the caspase cascade. Moreover, it has been shown that calpain-proteolysed procaspases may cause inactivation of the caspase cascade [12] . Our findings further underscore the importance of Ca 2+ in vascular biology and also illustrate a novel mechanism that may underlie the effectiveness of Ca 2+ -channel blockers as atheroprotective agents [48, 49] . This is also supported by previous results obtained in our laboratory [50] , as well as by other workers [4] , showing that Ca 2+ -channel blockers inhibit apoptosis induced by 25-hydroxycholesterol or oxLDL.
